Number (%) of Subjects | (N=44) |
---|---|
Sex | Â |
Male | 31 (70.5) |
Female | 13 (29.5) |
Age (years) | Â |
Mean (SD) | 57.8 (12.3) |
Range | 26-80 |
Age Category | Â |
<65 | 31 (70.5) |
≥65 | 13 (29.5) |
Race | Â |
White | 41 (93.2) |
Black | 2 (4.5) |
Asian | 1 (2.3) |
ECOG performance status | Â |
0 | 30 (68.2) |
1 | 14 (31.8) |
Current disease stage | Â |
IIIc | 1 (2.3) |
IV M1a | 9 (20.5) |
IV M1b | 11 (25.0) |
IV M1c | 23 (52.3) |
Measurable disease and adequate baseline assessment | Â |
Yes | 37 (84.1) |
No | 4 (9.1) |
Not reported | 3 (6.8) |
Number of involved disease sites | Â |
1 | 4 (9.1) |
2 | 9 (20.5) |
3 | 8 (18.2) |
4 | 5 (11.4) |
>4 | 18 (40.9) |
ECOG = Eastern Co-operative Oncology Group |